Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation
- 514 Downloads
This study aims to describe the clinical and molecular presentation of pediatric neurofibromatosis type 2 (NF2) and the subsequent management of vestibular schwannomas (VS) and hearing rehabilitation.
This is a single-center retrospective study of neurofibromatosis type 2 diagnosed before the age of 18 years old from 1997. Natural history of vestibular schwannomas and surgical outcomes were evaluated using volumetric MRI, hearing, and facial nerve assessment. Patients included in chemotherapy protocols were excluded.
From a database of 80 patients followed up for NF2 on a regular basis, 25 patients were eligible (11 sporadic cases, 14 inherited in five families). The mean age at diagnosis was 11.6 years old. The average clinical follow-up was 6.5 years. NF2 mutation was identified in 81 % of the probands. The average growth rate based on the maximum linear diameter (DGR) was 1.68 mm/year (n = 33, average follow-up 4.22 years) and 545 mm3/year in volumetric assessment (VGR) for VS larger than 1 cm (n = 21, average follow-up 3.4 years). In unoperated ears, hearing was stable in about 50 % of ears. The mean change in dB HL was 9.5 dB/year for pure-tone average and 3.5 for speech-recognition threshold (n = 34, 5.5 years 1–12). Eight children required removal through a translabyrinthine approach (mean follow-up was 4.5 years), six patients were operated on for hearing preservation (mean postoperative follow-up 4.3 years). Six patients were eligible for hearing rehabilitation with cochlear implantation (I), and five received placement of an auditory brainstem implant.
Early diagnosis and treatment of small growing VS should be carefully discussed considering familial history and possible rehabilitation with a CI.
KeywordsNeurofibromatosis type 2 Vestibular schwannoma Middle fossa Hearing préservation Auditory brainstem implant
Loss of heterozygocity
Neurofibromatosis type 2
Posterior subcapsular cataract
Dr. Nicolas-Xavier Bonne conceptualized and designed the study, drafted the initial manuscript, and approved the final manuscript as submitted. Dr. Rabih Aboukais helped in data collection and approved the final manuscript as submitted. Dr. Marc Baroncini participated in data collection, reviewed and revised the manuscript, and approved the final manuscript as submitted. Dr. Audrey Hochart critically reviewed the manuscript and approved the final manuscript as submitted. Dr. Pierre Leblond critically reviewed the manuscript and approved the final manuscript as submitted. Dr. Franck Broly critically reviewed the manuscript and approved the final manuscript as submitted. Dr. Frederique Dubrulle critically reviewed the manuscript and approved the final manuscript as submitted. Pr. Jean-Paul Lejeune critically reviewed the manuscript and approved the final manuscript as submitted. Pr. Christophe Vincent supervised the work, critically reviewed the manuscript, and approved the final manuscript as submitted.
Compliance with ethical standards
No external funding was secured for this study.
All authors have no financial relationships relevant to this article to disclose.
Conflict of interest
All authors have no conflicts of interest to disclose.
- 12.Evans DGR, Ramsden RT, Shenton A, et al. (2007) Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification. J Med Genet 44:424–428. doi: 10.1136/jmg.2006.047753 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Niemczyk K, Dubrulle F, Vaneecloo FM, et al. (2002) Clinical implications of acoustic neuromas growth rate in volumetric study. Ann Oto-Laryngol Chir Cervico Faciale Bull Société Oto-Laryngol Hôpitaux Paris 119:259–263Google Scholar
- 31.Goddard JC, Schwartz MS, Friedman RA (2010) Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 31:1128–1134. doi: 10.1097/MAO.0b013e3181e8fc3f CrossRefGoogle Scholar
- 32.Vincent C, Bonne N-X, Guérin C, et al. (2012) Middle fossa approach for resection of vestibular schwannoma: impact of cochlear fossa extension and auditory monitoring on hearing preservation. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 33:849–852. doi: 10.1097/MAO.0b013e318254ede3 CrossRefGoogle Scholar
- 34.Tringali S, Ferber-Viart C, Fuchsmann C, et al. (2010) Hearing preservation in retrosigmoid approach of small vestibular schwannomas: prognostic value of the degree of internal auditory canal filling. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 31:1469–1472Google Scholar